Clinical Trial: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Treatment Protocol for Ganaxolone as add-on Therapy in Adult Patients With Uncontrolled Partial-onset Seizures Deriving Benefit From Protocol 1042-0601

Brief Summary: This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.

Detailed Summary:
Sponsor: Marinus Pharmaceuticals

Current Primary Outcome: safety as determined by adverse events [ Time Frame: one year ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Marinus Pharmaceuticals

Dates:
Date Received: October 16, 2009
Date Started: October 2009
Date Completion:
Last Updated: October 1, 2015
Last Verified: October 2015